Radiesse®
A calcium hydroxylapatite injectable discussed for immediate volume plus biostimulatory educational framing. Not a ranking versus PLLA or HA.
Product Family pages are educational. Quorenne does not recommend one product over another, provide dosing or technique, select providers, or determine whether any product is appropriate for you. Important Information · Scientific Philosophy · Editorial Standards
You may also want to understand
Ask about Radiesse®
Suggested questions keep this page in mind. You can also ask anything else across Quorenne.
What it is
Radiesse® is a calcium hydroxylapatite (CaHA) microsphere gel. Educationally, it provides immediate contour with a biostimulatory conversation as the carrier gel is metabolized.
Context. Commonly associated with Merz Aesthetics. This is identifying context—not an endorsement.
Typical U.S. cost
About $600–$1,800 per syringe
Estimated U.S. range. Actual cost varies by provider, location, treatment area, product/device, and treatment intensity.
This figure is priced per syringe—not per treatment.
How it differs from other products in its category
Compared with HA fillers, CaHA is not primarily a hyaluronic hydrogel and is not reversed with hyaluronidase in the same way. Compared with PLLA, onset is often more immediate. These are mechanism differences—not a ranked preference.
Other educational pages in this family:
FDA-approved indications (general educational overview)
- Labeling has included correction of moderate to severe facial wrinkles and folds (such as nasolabial folds) and volume loss in the dorsum of the hands—verify current labeling.
- Other aesthetic uses may be off-label; ask your clinician.
- Hyperbolic dilution or “biostimulatory” protocols may differ from labeled use—clarify regulatory framing.
Always verify current product labeling. Quorenne does not reproduce full prescribing information.
Cosmetic and therapeutic uses
Cosmetic (high level)
- Discussed for folds, contour, and hand volume education when labeled
- Sometimes discussed in diluted biostimulatory protocols—ask about evidence and labeling status
Therapeutic (high level)
- Certain medical soft-tissue contexts are clinician-directed
Typical onset and duration
Typical onset. Contour is often visible immediately; swelling can affect early appearance.
Typical duration. Educational ranges often cite about one year or more for some labeled uses; individual duration varies.
Ranges are educational. Individual results cannot be predicted by Quorenne.
Factors affecting results
- Product rheology and gel characteristics
- Injection plane and technique chosen by the clinician
- Individual anatomy, tissue quality, and healing
- Amount used and treatment area
- Aftercare and follow-up discussed with the clinician
What it does not do
- Behave identically to HA fillers for every indication
- Offer the same reversal options as HA gels
- Guarantee lift for advanced laxity
- Replace clinician evaluation of vascular anatomy and risk
Risks and limitations
- Swelling, bruising, tenderness, and temporary lumps
- Infection or inflammatory responses
- Vascular occlusion is uncommon but serious—seek urgent care for vision changes or severe pain
- Migration, Tyndall effect, or contour irregularities depending on product and placement
- Allergy or delayed nodules in some contexts
- Nodules or irregularities
- Cannot be dissolved with hyaluronidase like many HA gels
Common misconceptions
- It is just another HA filler.
- CaHA has no vascular risk.
- Diluted protocols are automatically safer or more effective for everyone.
Questions to ask your clinician
- What are your training and experience with this product?
- Is the planned use approved or cleared for this indication, or discussed off-label?
- How does this product compare with others in this category for my goals?
- What results are realistic for someone with my anatomy and medical history?
- What risks are most relevant to my skin tone, medications, and medical history?
- What recovery should I expect, and how are complications recognized and managed?
- Who will perform the procedure, and what follow-up is available?
- What alternatives should I consider before deciding?
Evidence and references
CaHA has clinical evidence for labeled facial and hand indications. Dilution protocols and off-label aesthetic uses require careful clinician discussion and are not endorsed here as routines.
- FDA product labeling and approval summaries (indication-specific) — Indications and language change; verify current labeling.
- Dermatology / aesthetic medicine society educational materials
- Quorenne editorial synthesis for consumer education
Reviewed. 2026-08-05
Continue Understanding
These resources build on what you’ve just learned.
Common Comparisons
Side-by-side learning people often open next.
- Retinol vs AdapaleneA comparison people often open while learning this topic.
- Benzoyl Peroxide vs Salicylic AcidA comparison people often open while learning this topic.
- Mineral vs Chemical SunscreenA comparison people often open while learning this topic.
- Ceramides vs Hyaluronic AcidA comparison people often open while learning this topic.
- Vitamin C vs NiacinamideA comparison people often open while learning this topic.
Learn Next
A calm learning path from this topic — not a random set of links.